Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 11, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
September 11, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
July 10, 2014
Lead Product(s) : Dirithromycin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Abdi Ibrahim
Deal Size : Inapplicable
Deal Type : Inapplicable